Search

everythinglearnresearchcommunity

for

Search:↓

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Non-drug methods like diet, supplements, and aromatherapy can help manage hair loss and its emotional impact.

The document concludes that facial feminization surgery improves psychological well-being and social acceptance for transgender individuals.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Most insurance companies do not cover extra gender-affirming surgeries, with coverage being low and inconsistent.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Minoxidil can help transgender males grow facial hair before starting testosterone therapy.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Finasteride effectively treats male hair loss, increasing length and thickness.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Many Korean patients with hair loss, skin allergies, and psoriasis use alternative medicine, but satisfaction is low.

Women with AGA often face anxiety, depression, and low self-esteem; psychological support is important.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.